Boehringer hits Teva with counterpunch in inhaler patent battle

Intellectual Property 2019-03-04 9:53 pm By Cat Fredenburgh | Melbourne

German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.